Chile Blood-based Biomaker For Sports Medicine Market Size & Outlook

The blood-based biomaker for sports medicine market in Chile is expected to reach a projected revenue of US$ 6.1 million by 2030. A compound annual growth rate of 4.4% is expected of Chile blood-based biomaker for sports medicine market from 2024 to 2030.
Revenue, 2023 (US$M)
$4.5
Forecast, 2030 (US$M)
$6.1
CAGR, 2024 - 2030
4.4%
Report Coverage
Chile

Chile blood-based biomaker for sports medicine market, 2018-2030 (US$M)

Chile

Related Markets

Chile blood-based biomaker for sports medicine market highlights

  • The Chile blood-based biomaker for sports medicine market generated a revenue of USD 4.5 million in 2023 and is expected to reach USD 6.1 million by 2030.
  • The Chile market is expected to grow at a CAGR of 4.4% from 2024 to 2030.
  • In terms of segment, ck was the largest revenue generating type in 2023.
  • CRP is the most lucrative type segment registering the fastest growth during the forecast period.


Blood-based biomaker for sports medicine market data book summary

Market revenue in 2023USD 4.5 million
Market revenue in 2030USD 6.1 million
Growth rate4.4% (CAGR from 2023 to 2030)
Largest segmentCk
Fastest growing segmentCRP
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6


Other key industry trends

  • In terms of revenue, Chile accounted for 0.7% of the global blood-based biomaker for sports medicine market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 25.0 million by 2030.

Ck was the largest segment with a revenue share of 17.78% in 2023. Horizon Databook has segmented the Chile blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.


In Chile, there is a growing focus on enhancing sports infrastructure and increasing participation across the country. Over the past decade, the Chilean State has consistently invested in the sports sector, allocating an annual average of over USD 140.8 million to its national sports budget. Between 2009 and 2018, this budget increased in 5 years, reflecting the government’s commitment to developing sports facilities and programs.

As sports participation rises, there is a corresponding demand for advanced medical technologies, particularly in sports medicine. This growth aligns with the country’s broader investment in sports, ensuring that athletes receive top-tier medical care and support, enhancing their performance and overall well-being.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Blood-based Biomaker for Sports Medicine Market Companies

Name Profile # Employees HQ Website

Chile blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)

Chile Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)

Chile blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more